rs4938723

This is a upstream gene variant variant in the BTG4 gene.

Research that mentions this SNP (4)

Association between rs4938723 polymorphism and the risk of primary open‐angle glaucoma (POAG) in a Chinese population
AssociationN=718Jian Zhang et al.(2019)· Journal of Cellular Biochemistry

Case-control study of 366 POAG patients and 352 controls in a Chinese population found that rs4938723 C/T polymorphism in the miR-34b promoter is associated with reduced primary open-angle glaucoma (POAG) risk. CT/CC genotypes showed significantly decreased POAG risk (OR 1.89, 95% CI 1.40-2.54, p<0.0001), while CC homozygotes had the strongest protective effect (OR 2.28, p=0.0029). Functional studies demonstrated that the C allele increases miR-34b promoter activity and suppresses TP53 expression, reducing retinal ganglion cell apoptosis.

Traits studied:Primary open-angle glaucoma (POAG)
A functional polymorphism in MIR196A2 is associated with risk and prognosis of gastric cancer
ReviewShizhi Wang et al.(2013)· Molecular Carcinogenesis

This comprehensive review analyzes microRNA-related single nucleotide polymorphisms (SNPs) in gastric cancer, focusing on the most commonly studied variants including pre-miR-146a rs2910164, pre-miR-196a2 rs11614913, pre-miR-149 rs2292832, and pre-miR-499 rs3746444. The paper reviews 45 studies examining associations between miRNA polymorphisms and gastric cancer risk, including 18 studies on rs2910164 showing conflicting results (OR range 0.81-1.58), 13 studies on rs11614913 with no overall significant association, and analysis of pri-miRNA, pre-miRNA, promoter, and 3'-UTR variants. Additional variants identified include rs712 in let-7 (OR = 3.05; 95% CI = 1.53-6.08), rs12904 in miR-200c (OR = 0.65; 95% CI = 0.50-0.85), and rs12537 in miR-181a (OR = 1.72; 95% CI = 1.36-2.16).

Traits studied:Digestive system cancerGastric cancerGastrointestinal cancerNon-small cell lung cancer
A polymorphism at the miR‐502 binding site in the 3′‐untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome
AssociationN=858Zhanjun Guo et al.(2012)· International Journal of Cancer

Case-control study of 286 HCC patients and 572 controls in a Chinese population found that the TC and CC genotypes of pri-miR-34b/c rs4938723 were significantly associated with increased hepatocellular carcinoma risk (TC: OR = 1.46, 95% CI = 1.06-2.01; CC: OR = 3.07, 95% CI = 1.77-5.34; recessive model CC: OR = 2.50, 95% CI = 1.49-4.22).

Traits studied:Hepatocellular carcinoma
A potentially functional polymorphism in the promoter region of miR‐34b/c is associated with an increased risk for primary hepatocellular carcinoma
ReviewYan Xu et al.(2011)· International Journal of Cancer

Literature review of non-coding RNAs (microRNAs and long non-coding RNAs) in hepatocellular carcinoma pathogenesis, covering their diagnostic, prognostic, and therapeutic potential. Reviews aberrant miRNA expression patterns including upregulation of miR-21, miR-155, miR-221/222 and downregulation of miR-26a, miR-29, miR-122, and discusses polymorphisms in miRNA genes associated with HCC risk in Chinese and Turkish populations.

Traits studied:CirrhosisHepatocellular carcinomaLiver cancer

About BTG4

The protein encoded by this gene is a member of the BTG/Tob family. This family has structurally related proteins that appear to have antiproliferative properties. This encoded protein can induce G1 arrest in the cell cycle. [provided by RefSeq, Jul 2008]

View all BTG4 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…